Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Catheter Cardiovasc Interv ; 89(1): 144-153, 2017 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-27152677

RESUMEN

BACKGROUND: Women comprise almost 50% of patients undergoing transcatheter aortic valve replacement (TAVR) and previous studies have indicated higher rates of procedural complications and bleeding in women compared to men. It is unknown whether men and women demonstrate a differential response to bivalirudin versus unfractionated heparin (UFH) in TAVR. We sought to evaluate outcomes by sex and type of anticoagulant from the Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement (BRAVO-3) trial of transfemoral TAVR. METHODS: BRAVO-3 was a randomized multicenter trial comparing transfemoral TAVR with bivalirudin versus UFH (31 centers, n = 802). The primary endpoint was 48 h major bleeding defined as Bleeding Academic Research Consortium (BARC) type ≥3b. Major adverse cardiovascular events (MACE) were a composite of 30-day death, myocardial infarction, or stroke. Net adverse cardiovascular events (NACE) were a composite of BARC ≥3b bleeding or 30-day MACE. We examined the outcomes in men and women. RESULTS: The total cohort included 49% women (n = 391, 195 received bivalirudin and 196 UFH) and 51% men (n = 411, 209 received bivalirudin and 202 UFH). Women were older than men with fewer comorbidities including coronary artery disease, atrial fibrillation, diabetes but similar EuroSCORE I. Women received smaller sheath and device sizes compared with men without differences in the use of vascular closure devices. At 48-hr post-TAVR there was no difference in bleeding or vascular complications in women compared to men. The use of bivalirudin did not result in significantly lower bleeding at 48 hr or 30-days compared to UFH. CONCLUSIONS: There was no difference in early outcomes with bivalirudin versus UFH in men or women undergoing contemporary TAVR. © 2016 Wiley Periodicals, Inc.


Asunto(s)
Anticoagulantes/uso terapéutico , Antitrombinas/uso terapéutico , Estenosis de la Válvula Aórtica/terapia , Válvula Aórtica , Cateterismo Cardíaco , Implantación de Prótesis de Válvulas Cardíacas , Heparina/uso terapéutico , Fragmentos de Péptidos/uso terapéutico , Anciano , Anciano de 80 o más Años , Anticoagulantes/efectos adversos , Antitrombinas/efectos adversos , Válvula Aórtica/diagnóstico por imagen , Válvula Aórtica/fisiopatología , Estenosis de la Válvula Aórtica/diagnóstico por imagen , Estenosis de la Válvula Aórtica/mortalidad , Estenosis de la Válvula Aórtica/fisiopatología , Cateterismo Cardíaco/efectos adversos , Cateterismo Cardíaco/instrumentación , Cateterismo Cardíaco/métodos , Cateterismo Cardíaco/mortalidad , Europa (Continente) , Femenino , Implantación de Prótesis de Válvulas Cardíacas/efectos adversos , Implantación de Prótesis de Válvulas Cardíacas/instrumentación , Implantación de Prótesis de Válvulas Cardíacas/métodos , Implantación de Prótesis de Válvulas Cardíacas/mortalidad , Hemorragia/inducido químicamente , Heparina/efectos adversos , Hirudinas/efectos adversos , Humanos , Masculino , Estudios Multicéntricos como Asunto , Infarto del Miocardio/etiología , América del Norte , Fragmentos de Péptidos/efectos adversos , Ensayos Clínicos Controlados Aleatorios como Asunto , Proteínas Recombinantes/efectos adversos , Proteínas Recombinantes/uso terapéutico , Estudios Retrospectivos , Factores de Riesgo , Factores Sexuales , Accidente Cerebrovascular/etiología , Factores de Tiempo , Resultado del Tratamiento
2.
Int J Cardiol ; 266: 56-60, 2018 Sep 01.
Artículo en Inglés | MEDLINE | ID: mdl-29887473

RESUMEN

PURPOSE: Aortic stenosis (AS) in bicuspid aortic valve (BAV) remains a challenge for transcatheter aortic valve implantation (TAVI). BAV is a condition encountered in young adults as well as elderly patients. Frequently we face in clinical practice elderly patients with BAV and severe AS, but there is little evidence concerning TAVI in this population. The aim of our study was to compare anatomic features and outcomes of bicuspid and tricuspid patients with AS undergoing TAVI. METHODS: 83 consecutive BAV patients undergoing TAVI were matched, in a 1:2 ratio, to 166 tricuspid patients. Multi-detector computed tomography (MDCT) and transthoracic echocardiogram (TTE) were assessed at baseline. Primary endpoint was all-cause mortality and early safety at 30 days according to Valve Academic Research Consortium criteria 2 (VARC-2). Secondary endpoint included device success. RESULTS: BAV patients presented more aortic root calcifications, smaller diameter of left ventricular outflow tract (LVOT) and dilated aorta. We did not observe any statistically significant difference concerning all-cause mortality and early safety at 30 days. However higher intra-procedural TAV-in-TAV bailout procedure was observed in the BAV cohort, with consequent reduction of device success rate. CONCLUSIONS: Patients with BAV present more complex anatomy at baseline as compared to tricuspid AS patients. These anatomical features lead to more frequent TAV-in-TAV bailout procedure and lower device success rate, but are not associated with higher mortality rate at 30 days. Our findings support the feasibility of TAVI in BAV, but larger studies with longer follow-up and a focus on sizing are required.


Asunto(s)
Válvula Aórtica/anomalías , Válvula Aórtica/anatomía & histología , Válvula Aórtica/diagnóstico por imagen , Enfermedades de las Válvulas Cardíacas/diagnóstico por imagen , Reemplazo de la Válvula Aórtica Transcatéter/mortalidad , Reemplazo de la Válvula Aórtica Transcatéter/tendencias , Anciano , Anciano de 80 o más Años , Enfermedad de la Válvula Aórtica Bicúspide , Estudios de Cohortes , Femenino , Estudios de Seguimiento , Humanos , Masculino , Mortalidad/tendencias , Tomografía Computarizada Multidetector/mortalidad , Tomografía Computarizada Multidetector/tendencias , Resultado del Tratamiento
3.
Ann Cardiol Angeiol (Paris) ; 56(6): 316-8, 2007 Dec.
Artículo en Francés | MEDLINE | ID: mdl-17963717

RESUMEN

Pseudoaneurysm is a rare complication of left ventricle myocardial infarction. Rupture with tamponade and sudden death is the usual outcome. Surgical intervention remains the treatment of choice. Long term survival cases without surgery are rare. Infection of the thrombus is also a possible event. We report the case of a patient with postinfarction left ventricular pseudoaneurysm complicated by infection of the thrombus and purulent pericarditis involving a peptostreptococcus. Infection must be considered a potential complication of left ventricular pseudoaneurysms.


Asunto(s)
Aneurisma Falso/complicaciones , Aneurisma Cardíaco/complicaciones , Ventrículos Cardíacos/patología , Pericarditis/etiología , Trombosis/etiología , Adulto , Infecciones por Bacterias Grampositivas/diagnóstico , Humanos , Masculino , Infarto del Miocardio/complicaciones , Peptostreptococcus/aislamiento & purificación , Pericarditis/microbiología , Trombosis/microbiología
4.
Arch Mal Coeur Vaiss ; 99(9): 823-7, 2006 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17067102

RESUMEN

The effectiveness of thrombolytics has been clearly demonstrated in more than half the cases in the large cohorts of patients selected for trials during the acute phase of myocardial infarction. At individual level, thrombolysis will clinically either succeed or fail so, for the medical team managing the patient, choice of treatment may be likened to a gamble which in the best of cases (most often) leads to an uncomplicated success and, in the worst of cases, failure worsened by a severe complication. OPTIMAL is a multidisciplinary and multicentre, prospective cohort study associating mobile medical teams and interventional cardiology units to test the hypothesis that the outcome of prehospital thrombolysis does not depend on chance alone but also varies according to demographic, etiological, clinical and logistic factors involved in the occurrence and management of myocardial infarction. The primary objective of this French study, conducted over one year on more than 800 subjects, is to identify the predictors of the results of prehospital thrombolysis from a very early angiographic evaluation. The results for this cohort may be useful for setting up appropriate management strategies for acute myocardial infarction, from the prehospital phase (thrombolysis or not) up to in-hospital orientation of the patients (angiography room or Intensive Care Unit) and to determine the most judicious time for coronary angiography. OPTIMAL is to date the largest prospective serie of prehospital thrombolysis evaluated by an early angiographic control.


Asunto(s)
Servicios Médicos de Urgencia/organización & administración , Infarto del Miocardio/tratamiento farmacológico , Proyectos de Investigación , Terapia Trombolítica , Angiografía Coronaria , Recolección de Datos/métodos , Electrocardiografía , Francia , Humanos , Infarto del Miocardio/diagnóstico por imagen , Selección de Paciente , Estudios Prospectivos , Sistema de Registros
5.
Ann Cardiol Angeiol (Paris) ; 55(3): 164-8, 2006 Jun.
Artículo en Francés | MEDLINE | ID: mdl-16792035

RESUMEN

The authors report a case of paroxysmal, complete atrioventricular block during an anterior acute myocardial infarction, leading to asystolia. The different possible physiopathological mechanisms are discussed, suggesting a paroxysmal nodal conduction defect, secondary to transient parasympathetic stimulation, triggered by a Bezold-Jarish type of cardiac reflex. This reflex is frequently involved in various pathologic situations or diagnostic procedures, usual in cardiology. Although it is frequently observed in inferior myocardial infarction, it can occur during an anterior acute myocardial infarction.


Asunto(s)
Paro Cardíaco/etiología , Infarto del Miocardio/complicaciones , Anciano , Fibrilación Atrial/etiología , Nodo Atrioventricular/fisiopatología , Barorreflejo/fisiología , Estimulación Cardíaca Artificial , Femenino , Estudios de Seguimiento , Bloqueo Cardíaco/etiología , Humanos , Reflejo Anormal/fisiología , Resucitación
6.
Biomed Res Int ; 2013: 847069, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-24175304

RESUMEN

BACKGROUND: There is no data about the serotonergic activity during the acute phase of Tako-Tsubo Cardiomyopathy (TTC). The objective of our study was to investigate evidence of serotonin release from patients with TTC in comparison with patients with ST elevation myocardial infarction (STEMI) and healthy control subjects (HCS). METHODS AND RESULTS: Plasma serotonin levels in 14 consecutive patients with TTC were compared with those in 14 patients with STEMI and 14 HCS. Plasma serotonin levels at admission were markedly higher in patients with TTC and STEMI as compared to HCS (3.9 ± 4.6, P = 0.02 versus control; 5.7 ± 5.6, P = 0.001 versus control; and 1 ± 0.4 ng/mL, resp.). There was no difference in serotonin levels between patients with TTC and those with STEMI (P = 0.33). CONCLUSION: This finding suggests that serotonin could participate to the pathophysiology of TTC.


Asunto(s)
Serotonina/sangre , Cardiomiopatía de Takotsubo/sangre , Anciano , Anciano de 80 o más Años , Estudios de Casos y Controles , Femenino , Humanos , Masculino , Persona de Mediana Edad , Infarto del Miocardio/sangre , Aturdimiento Miocárdico/sangre , Serotonina/fisiología , Estrés Fisiológico , Estrés Psicológico , Cardiomiopatía de Takotsubo/etiología , Cardiomiopatía de Takotsubo/fisiopatología
7.
Ann Cardiol Angeiol (Paris) ; 59(6): 362-6, 2010 Dec.
Artículo en Francés | MEDLINE | ID: mdl-21056404

RESUMEN

Cardiogenic shock is the leading cause of in-hospital death for myocardial infarction. Despite therapeutic improvements, such as medical treatment with inotropes, myocardial revascularization, circulatory assistance can be an option. Intra-aortic balloon pumping is highly recommended in the presence of haemodynamic impairment. If the patient continues to deteriorate and cardiac function cannot maintain adequate circulation to prevent end-organ failure, several mechanical circulatory assist devices can be considered: extracorporeal membrane oxygenator (ECMO), Impella(®)… These devices should be used at tertiary centres either as bridge to recovery or as bridge to transplantation or as bridge to long-term left ventricle assist device.


Asunto(s)
Corazón Auxiliar , Choque Cardiogénico/cirugía , Humanos
9.
J Mol Cell Cardiol ; 42(3): 526-39, 2007 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-17222424

RESUMEN

Obesity is a risk factor for heart failure through a set of hemodynamic and hormonal adaptations, but its contribution at the molecular level is not clearly known. Therefore, we investigated the kinetic cardiac transcriptome and metabolome in the Spontaneous Hypertensive Heart Failure (SHHF) rat. The SHHF rat is devoid of leptin signaling when homozygous for a mutation of the leptin receptor (ObR) gene. The ObR-/- SHHF rat is obese at 4 months of age and prone to heart failure after 14 months whereas its lean counterpart ObR-/+ is prone to heart failure after 16 months. We used a set of rat pangenomic high-density macroarrays to monitor left ventricle cardiac transcriptome regulation in 4- and 10-month-old, lean and obese animals. Comparative analysis of left ventricle of 4- and 10-month-old lean rat revealed 222 differentially expressed genes while 4- and 10-month-old obese rats showed 293 differentially expressed genes. (1)H NMR analysis of the metabolome of left ventricular extracts displayed a global decrease of metabolites, except for taurine, and lipid concentration. This may be attributed to gene expression regulation and likely increased extracellular mass. The glutamine to glutamate ratio was significantly lower in the obese group. The relative unsaturation of lipids increased in the obese heart; in particular, omega-3 lipid concentration was higher in the 10-month-old obese heart. Overall, several specific kinetic molecular patterns act as a prelude to heart failure in the leptin signaling deficient SHHF obese rat.


Asunto(s)
Glutamatos/metabolismo , Glutamina/metabolismo , Insuficiencia Cardíaca/metabolismo , Membranas Intracelulares/metabolismo , Metabolismo de los Lípidos , Obesidad/metabolismo , Transcripción Genética/genética , Adaptación Biológica , Envejecimiento/fisiología , Animales , Perfilación de la Expresión Génica , Insuficiencia Cardíaca/genética , Espectroscopía de Resonancia Magnética , Masculino , Familia de Multigenes , Obesidad/genética , Análisis de Secuencia por Matrices de Oligonucleótidos , Fenotipo , Ratas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA